1 Toronto Street
Toronto, ON M5C 2E3
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees:
|Mr. David Attard||CEO, Pres & Director||92.61k||N/A||N/A|
|Mr. Scott Laitinen||Chief Financial Officer||475.93k||N/A||N/A|
|Mr. David Gordon||Chief Corp. Officer & Director||125.41k||N/A||N/A|
|Mr. Anthony W. Wile||Special Consultant||273.84k||N/A||N/A|
|Dr. Delon Human M.B.Ch.B., M.Prax.Med, MFGP, DCH, MBA||Global Head of Health & Innovation, Vice Chairman & Chairman of Medical & Scientific Advisory Board||N/A||N/A||N/A|
PharmaCielo Ltd., through its subsidiary, PharmaCielo Colombia Holdings S.A.S., cultivates, processes, produces, and supplies medicinal-grade cannabis oil extracts and related products in Colombia and internationally. It provides cannabidiol and tetrahydrocannabinol-focused cannabis oil extracts for channel distributors, including pharmacies, medical clinics, and cosmetic companies. The company was formerly known as Pan American Cannabis Inc. and changed its name to PharmaCielo Ltd. in September 2014. PharmaCielo Ltd. is headquartered in Toronto, Canada.
PharmaCielo Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.